Monique Adams, Ph.D.
Monique Adams is the Director of Janssen Clinical Innovation, where she leads the strategy development and implementation plans for innovation initiatives within patient centrality, non-conventional trial methods, and patient data for research areas. She also manages the innovation project leads.
Monique has a broad understanding of clinical development, gained through years of experience across Medical Affairs and Global Clinical Operations in different market environments. She comes to Janssen from Bristol-Myers Squibb (BMS) where she most recently developed the Clinical Trial Transparency capability which included building a team responsible for disclosure activities globally and the development of a registration & results reporting platform. She has provided thought leadership in this domain through multiple roles within TransCelerate, a biopharma consortium. In addition to her leadership over Clinical Trial Transparency, Monique had oversight for the non-clinical academic collaborations. She has a BS in biology, a MS in physiology, and earned her Ph.D. in pharmacology from University of Washington.